Trial intelligence / Profile preview

SELECT: Selenium and Vitamin E for Prostate Cancer Prevention

NCT00006392Phase 3Completed

Sponsor
SWOG Cancer Research Network
Start
Jul 2001
Primary completion
May 2011
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of vitamin e and selenium in prostate cancer (PCa) (4 arms), sponsored by SWOG Cancer Research Network. Primary endpoint: Number of Participants With Prostate Cancer. Started Jul 2001; status: completed.

02

Drugs

vitamin eselenium
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT00006392.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00006392.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call